Differential involvement of Ca2+/calmodulin-dependent protein kinases and mitogen-activated protein kinases in the dopamine D1/D5 receptor-mediated potentiation in hippocampal CA1 pyramidal neurons  by Shetty, Mahesh Shivarama & Sajikumar, Sreedharan
Neurobiology of Learning and Memory xxx (2016) xxx–xxxContents lists available at ScienceDirect
Neurobiology of Learning and Memory
journal homepage: www.elsevier .com/ locate/ynlmeDifferential involvement of Ca2+/calmodulin-dependent protein kinases
and mitogen-activated protein kinases in the dopamine D1/D5 receptor-
mediated potentiation in hippocampal CA1 pyramidal neuronshttp://dx.doi.org/10.1016/j.nlm.2016.07.020
1074-7427/ 2016 The Author(s). Published by Elsevier Inc.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
⇑ Corresponding author at: Department of Physiology, Block MD9, 2 Medical
Drive, Yong Loo Lin School of Medicine, National University of Singapore, 117597,
Singapore.
E-mail address: phssks@nus.edu.sg (S. Sajikumar).
Please cite this article in press as: Shetty, M. S., & Sajikumar, S. Differential involvement of Ca2+/calmodulin-dependent protein kinases and mitoge
vated protein kinases in the dopamine D1/D5 receptor-mediated potentiation in hippocampal CA1 pyramidal neurons. Neurobiology of Learning an
ory (2016), http://dx.doi.org/10.1016/j.nlm.2016.07.020Mahesh Shivarama Shetty, Sreedharan Sajikumar ⇑
Department of Physiology, Block MD9, 2 Medical Drive, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore
Neurobiology/Aging Program, 28 Medical Drive, Life Sciences Institute, National University of Singapore, Singapore
a r t i c l e i n f o a b s t r a c tArticle history:
Received 15 April 2016
Revised 21 July 2016








LTPDopaminergic neurotransmission modulates and influences hippocampal CA1 synaptic plasticity, learn-
ing and long-term memory mechanisms. Investigating the mechanisms involved in the slow-onset
potentiation induced by the dopamine D1/D5 receptor agonists in hippocampal CA1 region, we have
reported recently that it could play a role in regulating synaptic cooperation and competition. We have
also shown that a sustained activation of MEK/MAP kinase pathway was involved in the maintenance of
this long-lasting potentiation (Shivarama Shetty, Gopinadhan, & Sajikumar, 2016). However, the molec-
ular aspects of the induction of dopaminergic slow-onset potentiation are not known. Here, we investi-
gated the involvement of MEK/MAPK pathway and Ca2+-calmodulin-dependent protein kinases (CaMKII
and CaMKIV) in the induction and maintenance phases of the D1/D5 receptor-mediated slow-onset
potentiation. We report differential involvement of these kinases in a dose-dependent manner wherein
at weaker levels of dopaminergic activation, both CaMKII and MEK1/2 activation is necessary for the
establishment of potentiation and with sufficiently stronger dopaminergic activation, the role of
CaMKII becomes dispensable whereas MEK activation remains crucial for the long-lasting potentiation.
The results are interesting in view of the involvement of the hippocampal dopaminergic system in a vari-
ety of cognitive abilities including memory formation and also in neurological diseases such as
Alzheimer’s disease and Parkinson’s disease.
 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Induction mechanism of long-term potentiation (LTP) involves
a transient rise in intracellular Ca2+ that in turn leads to the activa-
tion of many protein kinases (Lynch, 2004; Mayford, Siegelbaum, &
Kandel, 2012). These active protein kinases, such as, Ca2+/
calmodulin-dependent protein kinase II (CaMKII), mitogen-
activated protein kinases (MAPKs), protein kinase-A (PKA), Protein
kinase-C (PKC) and others link the transient calcium signals to sig-
nal transduction mechanisms essential for the expression of LTP
(Giese & Mizuno, 2013). However, the involvement of the kinases
in the induction and maintenance mechanisms differs between dif-
ferent types of LTP depending on the nature of the LTP-inducing
stimulus and the brain region (Baudry et al., 2015; Lynch, 2004;
Mayford et al., 2012).The NMDA receptor-dependent LTP in the hippocampal CA1
region is associated with activation of CaMKII as it is blocked by
the inhibitors of CaMKII (Malenka et al., 1989; Malinow,
Schulman, & Tsien, 1989). CaMKII remains persistently activated
even after the induction of LTP as a result of autophosphorylation
at Thr-286 (Fukunaga, Muller, & Miyamoto, 1995; Fukunaga,
Stoppini, Miyamoto, & Muller, 1993; Ouyang, Kantor, Harris,
Schuman, & Kennedy, 1997) and mutation of this site to prevent
autophosphorylation leads to impairments in LTP and learning
(Giese, Fedorov, Filipkowski, & Silva, 1998). Further, mice lacking
the CaMKII gene also show deficient hippocampal LTP and
impaired spatial learning (Silva, Paylor, Wehner, & Tonegawa,
1992; Silva, Stevens, Tonegawa, & Wang, 1992), and CaMKII inhibi-
tors block the potentiation induced by activation of cAMP path-
ways (Makhinson, Chotiner, Watson, & O’Dell, 1999). On the
other hand, CaMKII is not involved in the LTP induction during
early development (Yasuda, Barth, Stellwagen, & Malenka, 2003)
and in certain other hippocampal synapses (Cooke et al., 2006).
Recent evidence shows that LTP can be induced in CA1 region inn-acti-
d Mem-
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Giese, & Ris, 2014). Therefore, the extent of involvement of CaMKII
in the LTP induction and expression could differ with the type of
LTP-inducing stimulus.
MAP-kinases ERK1 (p44 MAPK) and ERK2 (p42 MAPK) are one
of the key signal integrators in various forms of LTP and its associa-
tivity (Shivarama Shetty, Gopinadhan, & Sajikumar, 2016; Sweatt,
2001) and are known to contribute to both local and nuclear mech-
anisms following a plasticity inducing event [(Reviewed in (Davis
& Laroche, 2006)]. Dopaminergic neurotransmission through D1-
like receptors influences protein synthesis-dependent late phase-
LTP and long-term memory in the hippocampus (Frey, Matthies,
& Reymann, 1991; Hansen & Manahan-Vaughan, 2014; Jay, 2003;
Rossato, Bevilaqua, Izquierdo, Medina, & Cammarota, 2009). Nota-
bly, a synergistic interaction between dopamine D1 receptors and
NMDA receptors involves ERK1/2 signaling mechanisms in rat hip-
pocampus (Sarantis, Matsokis, & Angelatou, 2009) and application
of dopamine to acute hippocampal slices leads to robust activation
of ERK2 in CA1 region (Roberson et al., 1999). However, MAPKs
could be differentially involved in the different phases of plasticity
as reported in Aplysia (Sharma et al., 2003).
Interestingly, dopamine or D1/D5 receptor agonists induce a
long-lasting, slow-onset potentiation (SOP) in hippocampal CA1
Schaffer collateral synapses (Huang & Kandel, 1995; Navakkode,
Sajikumar, & Frey, 2007; Navakkode, Sajikumar, Korte, & Soong,
2012) suggesting that D1/D5 receptor activation may be involved
in the mechanisms of tag-setting and expression of synaptic tag-
ging and capture (STC), a widely studied model for associative plas-
ticity (Redondo & Morris, 2011). We have recently reported that
the D1/D5 receptor-mediated potentiation could lead to differen-
tial activation of intracellular mechanisms involving sustained
activation of MEK/MAPK pathway in a dose-dependent manner
and thus influence STC (Shivarama Shetty et al., 2016). However,
whether CaMKs and MAPKs regulate the induction mechanism of
dopaminergic potentiation, specifically in a dose-dependent man-
ner, is not known. Here, we have investigated the differential
involvement of MAPKs and CaMKs in the induction and mainte-
nance of the D1/D5 receptor agonist-induced potentiation in acute
hippocampal slices of adult rats.2. Materials and methods
2.1. Preparation of hippocampal slices
A total of 143 acute hippocampal slices prepared from eighty 5–
7 week old male Wistar rats were used in the study. All animal pro-
cedures were approved by the Institutional Animal Care and Use
Committee (IACUC) of National University of Singapore and can
be produced upon request. Briefly, after anaesthetization using
CO2, the rats were decapitated and the brains were quickly
removed to 4 C artificial cerebrospinal fluid (aCSF)—a modified
Krebs-Ringer solution containing the following (in mM): 124 NaCl,
3.7 KCl, 1.2 KH2PO4, 1 MgSO47H2O, 2.5 CaCl22H2O, 24.6 NaHCO3,
and 10 D-glucose. The pH of aCSF was between 7.3 and 7.4 when
bubbled with 95% oxygen and 5% carbon dioxide (carbogen). Right
hippocampus was dissected out in the cold (2–4 C) aCSF being
continuously bubbled with carbogen. Transverse hippocampal
slices of 400 lm thickness were prepared from the right hip-
pocampus using a manual tissue chopper (Stoelting, Wood Dale,
Illinois), transferred onto a nylon net in an interface chamber (Sci-
entific Systems Design, Ontario, Canada) and incubated at 32 C at
an aCSF flow rate of 1 ml/min and carbogen consumption of 16 l/h.
The slices were incubated for at least 3 h before starting the exper-
iments. For more details see (Shetty et al., 2015; Shivarama Shetty
et al., 2016).Please cite this article in press as: Shetty, M. S., & Sajikumar, S. Differential invo
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Monopolar, lacquer-coated, stainless steel electrodes (AM Sys-
tems) were used as stimulating (<1 MX) and recording electrodes
(5 MX). Stimulating electrodes were positioned within the stratum
radiatum of the CA1 region to stimulate Schaffer collaterals and the
field-EPSP responses were recorded with an electrode placed in the
CA1 distal apical dendritic region. After the pre-incubation period,
an input–output curve (stimulus intensity vs. fEPSP slope) was
plotted for each input and the test stimulus intensity was set to
obtain a fEPSP slope 40% of the maximal response. The signals were
amplified by a differential amplifier, digitized using a CED 1401
analog-to-digital converter (Cambridge Electronic Design, Cam-
bridge, UK) and monitored online with custom-made software. In
all experiments, a stable baseline was recorded for at least
30 min before starting the drug treatments. Four 0.2-Hz biphasic,
constant current pulses (spaced at 5 s) given every five minutes
were used for baseline and post-induction recording and the aver-
age slope value from the four sweeps was considered as one repeat
while used for plotting. Initial slopes of fEPSPs were expressed as
percentages of baseline averages.2.3. Drugs
The D1/D5 receptor agonist SKF-38393 [(±)-1-Phenyl-2,3,4,5-tet
rahedro-(1H)-3-benzazapine-7,8-diol hydrochloride] (SKF; #D047,
Sigma-Aldrich) was stored as 15–50 mM stock in deionised water
at 20 C protected from light. SKF was diluted to final concentra-
tion and bath applied to the slices at 1 ml/min flow rate for three 5-
min durations with a 5-min interval between each application
(Navakkode et al., 2007, 2012; Shivarama Shetty et al., 2016).
The CaM kinase inhibitor KN-93 and its inactive analog KN-92
were purchased from Calbiochem (#422708, #422712, #422709)
and reconstituted in DMSO to 5–20 mM stock and stored as ali-
quots at 20 C protected from light. KN-93, at low concentration
(1 lM) specifically inhibits CaMKII whereas at a higher concentra-
tion (10 lM) inhibits many CaM kinases, including CaMKII and
CaMKIV (Redondo et al., 2010). The MAPK/ERK kinase (MEK) inhi-
bitor U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]
butadiene) was purchased from Promega (#V1121), and stored as
aliquots of 20 mM stock in DMSO at 20 C.
Just before application, the stocks were diluted to the final con-
centration in aCSF and bubbled with carbogen. The drugs were pro-
tected from light during storage and the bath application was
carried out under dark conditions. Whenever the drug stock was
prepared in DMSO, the DMSO concentration in the final bath-
application solution was kept below 0.1%, a concentration which
has been shown to not affect basal synaptic responses
(Navakkode, Sajikumar, & Frey, 2005).2.4. Data presentation and statistics
The fEPSP slopes per time point were expressed as percentage
of average baseline values in each experiment. The time-
matched, normalized data were averaged across replicate experi-
ments, plotted against time as ‘mean ± SEM’ and were then sub-
jected to statistical analysis with GraphPad Prism 6.0.
Nonparametric tests were used considering the normality viola-
tions at small sample numbers. Wilcoxon matched-pairs signed
rank test was used when comparisons were made within a group
(a post-induction value compared to its own baseline value).
Mann-Whitney U test was used for comparisons between groups.
Statistical significance was assumed at P < 0.05. (*P < 0.05;
**P < 0.01; ***P < 0.001; ****P < 0.0001).lvement of Ca2+/calmodulin-dependent protein kinases and mitogen-acti-
n hippocampal CA1 pyramidal neurons. Neurobiology of Learning and Mem-
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3.1. Role of MEK/MAPK pathway in the induction phase of D1/D5
receptor-mediated potentiation
MEK/MAPK pathway can be activated within minutes following
a plasticity-inducing stimulus (Davis & Laroche, 2006). Hence, we
investigated whether MEK/MAPK activation during the induction
phase is critically involved in the SKF-induced potentiation. We
used the inhibitor U0126, which specifically targets the upstream
kinases of ERK1/2 called MEKs (MAP2Ks) (Favata et al., 1998).
U0126 potently inhibits both MEK1 and MEK2, and thus prevents
the activation of ERK1/2 [(IC50 of 72 nM for MEK1 and 58 nM for
MEK2); (Duncia et al., 1998)].
Following a stable baseline recording for 30 min, 5 lM U0126
was bath applied and 15 min later, SKF, at the respective concen-
tration, was co-applied in three pulses similar to that of earlier
reports (Navakkode et al., 2007, 2012; Shivarama Shetty et al.,
2016). Application of U0126 was continued for another 15 min
after the end of SKF application; thus, U0126 was applied for a total
duration of 55 min. Co-application of 5 lM SKF with 5 lM U0126
failed to induce any potentiation (Fig. 1B; n = 7). The mean fEPSP
slope values were not significantly different from the baseline val-
ues at any time-point during the entire period of recording (Wil-
coxon test, P > 0.05). The mean potentiation at the end of the
recording (100 ± 6%) was significantly less compared to that with-
out the inhibitor treatment [inset in Fig. 1B, (Shivarama Shetty
et al., 2016)]. The potentiation induced by 10 lM SKF was also
affected by the blockade of MEK1/2 activity (Fig. 1C; n = 7). Though
the induction was not affected and the potentiation became signif-
icantly different from the baseline by 20 min (113 ± 2% Wilcoxon
test, P = 0.015), the magnitude of potentiation did not follow the
time-course as that observed in the absence of U0126 [see inset
in Fig. 1C, (Shivarama Shetty et al., 2016)]. Further, the potentiation
was only transient and was not significantly different from the
baseline values by 140 min (120 ± 7%, Wilcoxon test, P = 0.078)
and decayed gradually to the baseline by the end of recording per-
iod (101 ± 6%, Wilcoxon test, P = 0.468).
Interestingly, co-application of U0126 blocked the persistence
of the potentiation induced by 25 lM SKF [Fig. 1D, n = 8; See inset
in Fig. 1D for control graph (Shivarama Shetty et al., 2016)]. The
induction was not affected; the potentiation became significantly
different from the baseline value 20 min after the start of SKF
application (117 ± 6%, Wilcoxon test, P = 0.039) and remained sig-
nificant until 160 min (124 ± 8%, Wilcoxon test, P = 0.039). From
165 min onwards the potentiation gradually decayed to the base-
line values by the end of the recording period (270 min; 101 ± 6%
Wilcoxon test, P = 0.843). The mean potentiation values 4 h follow-
ing application of different concentration of SKF with MEK inhibi-
tion were compared to those observed in the absence of MEK
inhibition [Fig. 1E; control data for comparison from (Shivarama
Shetty et al., 2016), used with permission]. Collectively, these
experiments indicated that MEK activation during the induction
phase was crucial for the long-lasting potentiation induced by
D1/D5 receptor activation.3.2. Role of CaMKII in the induction phase of D1/D5 receptor-mediated
potentiation
To investigate the role of CaMKII in the induction phase of D1/
D5 receptor-mediated potentiation, we made use of the specific
inhibitor of the CaM kinases, KN-93. KN-93 is a cell-permeable,
potent inhibitor with an IC50 of 0.37 lM for CaMKII (Sumi et al.,
1991). It has been reported earlier that at a concentration of
1 lM, KN-93 selectively inhibits the activity of CaMKII while spar-
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Fujisawa, 1995; Redondo et al., 2010). Therefore, we co-applied
1 lM KN-93 along with the different concentrations of D1/D5
receptor agonist SKF. Following stable baseline recording for
30 min, 1 lM KN-93 was bath applied and 15 min later, SKF, at
the respective concentration, was co-applied in three pulses. KN-
93 application was continued for another 15 min after the end of
SKF application i.e., KN-93 was applied for a total duration of
55 min.
Blocking the CaMKII activity with KN-93 during 5 lM SKF appli-
cation completely blocked the SKF-induced potentiation (Fig. 2A;
n = 7). No significant potentiation was observed at any time-
point over the entire recording period (Wilcoxon test, P > 0.05).
The mean potentiation at the end of recording was 106 ± 5% (Wil-
coxon test, P = 0.218). KN-92 application, however, did not affect
the induction or maintenance of the 5 lM SKF-induced potentia-
tion (Fig. 2B; n = 6). The mean potentiation at the end of the
recording period was 130 ± 4% (Wilcoxon test, P = 0.031). Interest-
ingly, co-application of KN-93 with 10 lM SKF resulted only in a
transient potentiation (Fig. 2C; n = 7). The potentiation became sig-
nificantly different from the baseline by 30 min following SKF
application (113 ± 3%, Wilcoxon test, P = 0.015). However, the
potentiation started decaying gradually after 165 min (111 ± 6%,
Wilcoxon test, P = 0.078) and was not significantly different from
the baseline values afterwards. The mean potentiation at the end
of the recording period was 104 ± 8% (Wilcoxon test, P = 0.468).
Application of KN-92 showed no effect on the maintenance of
10 lM SKF-induced potentiation (Fig. 2D; n = 6). The potentiation
became statistically significant 15 min onwards and maintained
for the entire recording period (Wilcoxon test, P = 0.031). Mean
potentiation at the end of the recording period was 135 ± 6%, (Wil-
coxon test, P = 0.031).
When KN-93 was applied in the above fashion along with
25 lM SKF, the potentiation followed the usual time course and
became significantly different from the baseline values 25 min
after the start of SKF application (Fig. 2E; 113 ± 3%, Wilcoxon test,
P = 0.023) and maintained over the entire recording period
(133 ± 5%, Wilcoxon test, P = 0.007, n = 8). The magnitude of poten-
tiation was less compared to that observed with KN-92 treatment,
which however, was not statistically significant (Mann-Whitney U
test, P > 0.05). The potentiation induced by 25 lM SKF was not
affected by the application of KN-92 (Fig. 2F; n = 7). Mean potenti-
ation at the end of the recording period was 153 ± 12% (Wilcoxon
test, P = 0.015).
A comparison of the mean potentiation values at the end of the
recording period between the different SKF concentration groups
with KN-93 and KN-92 treatment is shown in (Fig. 2G). Together,
these results indicate that at weaker D1/D5 receptor activation,
CaMKII has a crucial role in the induction of long-lasting forms of
plasticity. However, with stronger D1/D5 receptor activation its
role appears to be dispensable, possibly due to coincidental activa-
tion of many other kinases, the concerted action of which can com-
pensate for the blockade of CaMKII activity.
3.3. Role of CaMKII activity in the maintenance phase
Having observed the differential role of CaMKII in the induction
phase, we further investigated its involvement in the maintenance
phase of the potentiation induced by different concentrations of
SKF. Reports on the involvement of persistently active CaMKII in
the maintenance phases of LTP have been confounding (Malinow
et al., 1989; Feng, 1995; Chen, Otmakhov, Strack, Colbran, &
Lisman, 2001; Lengyel et al., 2004). Here, we tested whether per-
sistently active CaMKII is involved in the maintenance of D1/D5
receptor-mediated potentiation. As in the previous series of exper-
iments, we made use of the strategy of specific inhibition of CaMKIIlvement of Ca2+/calmodulin-dependent protein kinases and mitogen-acti-








Fig. 1. Role of MEK1/2 activation in the induction of D1/D5 receptor-mediated potentiation. (A) A schematic representation of the electrode location in the hippocampal CA1
region. Stimulating (S1) and recording (rec) electrodes were positioned in the stratum radiatum (sr) to evoke and record fEPSP responses at the Schaffer collateral (sc)
synapses. Following a stable baseline recording for 30 min, MEK inhibitor U0126 (5 lM) was bath applied and 15 min later, SKF, at the respective concentration, was co-
applied in three pulses (three broken arrows). The duration of U0126 application is represented with the grey bar in each case. (B) Inhibition of MEK activity completely
blocked the potentiation induced by 5 lM SKF (n = 7). (C) Coapplication of U0126 with 10 lM SKF blocked the late phase of the potentiation (n = 7). The potentiation decayed
to the baseline by the end of the recording period. (D) Inhibition of MEK1/2 activity also blocked the maintenance of the potentiation induced by 25 lM SKF (n = 8). (E) A
histogram comparing the mean potentiation values 4 h after SKF application in the different SKF concentration groups with or without U0126 coapplication. The ‘Control’
group for each SKF concentration is shown as inserts in each case [Reproduced from (Shivarama Shetty et al., 2016) with permission of the publisher]. Asterisks indicate
significant difference between two groups [(Mann-Whitney U test, *P < 0.05, **P < 0.01, ***P < 0.001); (For 5 lM SKF Group P = 0.046; for 10 lM SKF Group P = 0.006 and for
25 lM SKF Group P = 0.0002)]. Error bars in all graphs represent ±SEM. Representative fEPSP traces shown in each case were recorded at the respective time points as
mentioned. Scale bars for all the traces, vertical: 3 mV, horizontal: 5 ms.
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respective concentration, was applied to the slices as explained in
the initial experiments (Fig. 1). KN-93 (1 lM) was then bath
applied from 90 min after the start of SKF application throughout
the rest of the recording period. All these experiments were also
repeated with KN-92, an inactive analog of KN-93, to rule out
any non-specific treatment effects.Please cite this article in press as: Shetty, M. S., & Sajikumar, S. Differential invo
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ory (2016), http://dx.doi.org/10.1016/j.nlm.2016.07.020Blocking CaMKII activity with KN-93 during the maintenance
phase had no effect on 5 lM SKF-induced potentiation (Fig. 3A;
n = 7). The potentiation became significantly different from the
baseline slowly by 80 min (113 ± 4%, Wilcoxon test, P = 0.031),
remained statistically significant thereafter until the end of the
recording (129 ± 3%, Wilcoxon test, P = 0.015). The experiments
were repeated with the KN-92 treatment, which showed no non-lvement of Ca2+/calmodulin-dependent protein kinases and mitogen-acti-
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Fig. 2. Role of CaMKII in the induction of D1/D5 receptor-mediated potentiation. Following a stable baseline recording for 30 min, CaMKII inhibitor KN-93 (1 lM) or its
inactive analog KN-92 (1 lM) was bath applied and 15 min later, SKF, at the respective concentration, was co-applied in three pulses (three broken arrows). The duration of
KN-93 application is represented with the grey bar in each case. (A) Inhibition of CaMKII completely blocked the potentiation induced by 5 lM SKF (n = 7). (C) Coapplication
of 1 lM KN-93 with 10 lM SKF resulted in a transient potentiation (n = 7). The potentiation decayed to the baseline by the end of the recording period. (E) Inhibition of
CaMKII activation did not affect the maintenance of the potentiation induced by 25 lM SKF (n = 8) but the magnitude of potentiation was reduced. Coapplication of KN-92
(1 lM) had no effect on the induction or maintenance of the potentiation induced by (B) 5 lM SKF (n = 6), (D) 10 lM SKF (n = 6) and (F) 25 lM SKF (n = 7). (G) A histogram
comparing the mean potentiation values at the end of the recording period in the different SKF concentration groups with KN-93 or KN-92 coapplication. Asterisks indicate
significant difference between two groups [(Mann-Whitney U test, *P < 0.05, **P < 0.01); (For 5 lM SKF group P = 0.008; for 10 lM SKF group P = 0.022 and for 25 lM SKF
group P = 0.351)]. Error bars in all graphs represent ±SEM. Representative fEPSP traces shown in each case were recorded at the respective time points as mentioned. Symbols
and traces as in Fig. 1.
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Fig. 3. Role of CaMKII in the maintenance of D1/D5 receptor-mediated potentiation. Following a stable baseline recording for 30 min, SKF, at the respective concentration,
was co-applied in three pulses (three broken arrows). The CaMKII inhibitor KN-93 (1 lM) or its inactive analog KN-92 (1 lM) was bath applied starting 90 min after the SKF
application until the end of the recording. The duration of the inhibitor application is represented with the grey bar in each case. (A) and (B) Inhibition of CaMKII during
maintenance phase did not affect the potentiation induced by 5 lM SKF (n = 7) as compared to that with the control analog (n = 7). (C) and (D) The maintenance of
potentiation induced by 10 lM SKF was unaffected by the treatment with either the CaMKII inhibitor (n = 7) or the control drug KN-92 (n = 6). (E) and (F) Treatment with KN-
93 did not affect the maintenance of potentiation induced by 25 lM SKF (n = 7), similar to the treatment with KN-92 (n = 6). (G) A histogram comparing the mean
potentiation values at the end of the recording period in the respective SKF concentration groups with KN-93 or KN-92 treatment. No significant difference was observed
between the treatments in any group (Mann-Whitney U test; P > 0.05). Error bars in all graphs represent ± SEM. Representative fEPSP traces shown in each case were recorded
at the respective time points as mentioned. Symbols and traces as in Fig. 1.
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not significantly different from the KN-93 treatment group
(Mann-Whitney U test, P > 0.05).
Application of 1 lM KN-93 had no effect on the maintenance of
the potentiation induced by 10 lM SKF (Fig. 3C; n = 7) and 25 lM
SKF (Fig. 3E; n = 7). The mean potentiation at the end of the record-
ing period in both the cases was significantly different from the
respective baseline values (Wilcoxon test, P < 0.05). Similar poten-
tiation profile was also observed with 1 lM KN-92 treatment
(Fig. 3D; n = 6 and Fig. 3F; n = 6) and there was no statistically sig-
nificant difference between the respective KN-93 and KN-92 treat-
ment groups (Mann-Whitney U test, P > 0.05).
A histogram comparing the mean potentiation at the end of
recording period between the different SKF concentration groups
with KN-93 and KN-92 treatment is shown in Fig. 3G. Together,
these series of experiments showed that a sustained CaMKII activ-
ity is not involved in the maintenance phase of the D1/D5 receptor-
mediated potentiation irrespective of the strength of stimulation.
3.4. Role of CaM kinase-IV (CaMKIV) in the maintenance phase of D1/
D5 receptor-mediated potentiation
CaMKIV has been reported to take part in the induction of
activity-dependent gene transcription and thus contribute to cer-
tain forms of transcription and translation dependent plasticity
(Bito, Deisseroth, & Tsien, 1996; Kang et al., 2001; Kasahara,
Fukunaga, & Miyamoto, 2001; Redondo et al., 2010). CaMKIV is a
nuclear kinase and becomes activated after phosphorylation by
CaM kinase kinase (CaMKK) which, in turn, is activated by nuclear
calcium entry in response to strong stimulation. The active CaMKIV
then phosphorylates and activates CREB, thus leading to transcrip-
tion of plasticity-related genes (Bito et al., 1996; Kang et al., 2001;
Kasahara et al., 2001). We were interested to know whether CaM-
KIV activation was involved in the maintenance phase of the
potentiation induced by SKF. To investigate this, we made use of
the CaM kinase inhibitor KN-93 but now at a higher concentration
(10 lM), as it has been reported earlier that at this concentration
KN-93 effectively inhibits many CaM kinases, including CaMKIV
(Redondo et al., 2010).
The experimental strategy was similar to that followed in Sec-
tion 3.3 but 10 lM KN-93 was applied starting 90 min after the
SKF application and for the rest of the recording period. These
experiments were also repeated with the same concentration of
the inactive analog KN-92. The slow-onset, long-lasting potentia-
tion observed following 5 lM SKF application was not affected
by the 10 lM KN-93 treatment (Fig. 4A; n = 7). The potentiation
became statistically significant by 75 min after the SKF application
(109 ± 4%; Wilcoxon test, P = 0.046) and then lasted over 4 h. The
mean potentiation at the end of the recording (130 ± 7% Wilcoxon
test, P = 0.015) was similar to that in the KN-92 group (Fig. 4B;
131 ± 6%, Wilcoxon test, P = 0.031; n = 6) and when compared
between two groups, there was no significant difference in the
magnitude of potentiation (Mann-Whitney U test, P > 0.05). Treat-
ment with 10 lM KN-93 had no significant effect on the potentia-
tion induced by 10 lM SKF (Fig. 4C; n = 7). The potentiation
followed the usual time course becoming significantly different
from the baseline by 20 min after SKF application (114 ± 2%, Wil-
coxon test, P = 0.031) and maintained at significant levels through-
out the rest of the recording period (Wilcoxon test, P > 0.05). The
mean fEPSP slope at the end of the recording (134 ± 7% Wilcoxon
test, P = 0.015) was similar to that in the KN-92 treatment group
(Fig. 4D; 135 ± 8%, Wilcoxon test, P = 0.031; n = 6) and there was
no significant difference in the magnitude of potentiation when
compared between two groups (Mann-Whitney U test, P > 0.05).
Application of 25 lM SKF resulted in a slow-onset long-lasting
potentiation that became significantly different from the baselinePlease cite this article in press as: Shetty, M. S., & Sajikumar, S. Differential invo
vated protein kinases in the dopamine D1/D5 receptor-mediated potentiation i
ory (2016), http://dx.doi.org/10.1016/j.nlm.2016.07.020values 30 min onwards (Fig. 4E; 107 ± 2%, Wilcoxon test,
P = 0.023; n = 8) and lasted for the entire recording period
(270 min; Wilcoxon test, P = 0.007). Though the potentiation in
the late phase was not completely blocked by the treatment with
KN-93, the magnitude of potentiation was significantly less com-
pared to that observed in the KN-92 treatment group (Fig. 4F;
n = 6). When compared to the KN-92 treatment group, the potenti-
ation in KN-93 treatment group was significantly reduced 135 min
onwards (Mann-Whitney U test, P < 0.05). The mean potentiation
at the end of the recording was 131 ± 7% in KN-93 group whereas
it was 148 ± 7% in the KN-92 group. There was also a significant
difference in the mean potentiation at the end of recording period,
between the 25 lM SKF group [see insert in Fig. 1D; from
(Shivarama Shetty et al., 2016)] and the 10 lM KN-93 treatment
group (Mann-Whitney U test, P = 0.043). A histogram comparing
the mean potentiation at the end of recording between the differ-
ent SKF concentration groups with KN-93 and KN-92 treatment is
shown in Fig. 4G. Taken together, these results showed that the
active CaMKIV-mediated mechanisms contribute synergistically
to the maintenance phase of potentiation only with stronger D1/
D5R activation and were not activated by weaker D1/D5R
stimulation.
A summary of the effects of inhibition of MEKs and CaMKs dur-
ing the induction and maintenance phase of the D1/D5 receptor-
mediated potentiation are presented in Table 1A and B
respectively.4. Discussion
The experiments investigating the role of CaM kinases and
MEKs in the induction phase of D1/D5 receptor-mediated potenti-
ation revealed that at weaker levels of dopaminergic activation
with its agonist (5 lM SKF), inhibiting either of the kinases, CaMKII
or MEKs, completely blocked the induction of potentiation. At
moderate levels of dopaminergic activation (10 lM SKF), inhibition
of either of the kinases blocked the persistence of the potentiation.
However, when the dopaminergic activation was sufficiently
strong (25 lM SKF), inhibiting CaMKII during induction had no
effect on the induced potentiation whereas inhibiting MEKs
blocked the late phase. The late-phase mechanisms in this case
were gated through MEK activation. When the dopaminergic acti-
vation was moderate, potentiation could still be maintained tran-
siently by other active kinases but the expression of late-phase
would require active MEK. With weaker D1/D5 receptor activation,
a concerted action of these two kinases was necessary for the
induction of the potentiation and thus blocking any of them would
interfere with the induction.
Differential involvement of kinases in different forms of plastic-
ity has been well appreciated (Baudry et al., 2015; Lynch, 2004;
Mayford et al., 2012). Though CaMKII is known to be involved in
many forms of LTP in the hippocampus, its role is not ubiquitous
to all forms of NMDAR-dependent LTP: CaMKII inhibitors have no
effect on the LTP induction in CA1 during early development
(Yasuda et al., 2003) and its involvement is minimal in medial per-
forant path synapses of DG (Cooke et al., 2006). On the other hand,
inhibitors of MEK block theta-induced LTP while sparing tetanus-
induced or pairing-induced LTP (Opazo, Watabe, Grant, & O’Dell,
2003). Further, in some cases, CaMKII might play a role as a part
of a parallel cascade involving MAPK and PKA (Cooke et al.,
2006). Such parallel kinase cascades are known to operate in mice
at an early age (Wikstrom, Matthews, Roberts, Collingridge, &
Bortolotto, 2003), in the DG of adult mice (Cooke et al., 2006)
and in rats (Wu, Rowan, & Anwyl, 2006). From these studies, two
main limbs of such parallel cascades have been identified one
involving CaMKII and the other involving PKA/PKC/MAPK.lvement of Ca2+/calmodulin-dependent protein kinases and mitogen-acti-
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Fig. 4. Role of CaMKIV and other CaM-kinases in the maintenance of D1/D5 receptor-mediated potentiation. Following a stable baseline recording for 30 min, SKF, at the
respective concentration, was co-applied in three pulses as in earlier experiments. The CaM-Kinase inhibitor KN-93 (10 lM) or its inactive analog KN-92 (10 lM) was bath
applied starting 90 min after the SKF application until the end of the recording. The duration of the inhibitor application is represented with the grey bar in each case. (A) and
(B) Inhibition of CaMKIV and other CaMKs during maintenance phase did not affect the potentiation induced by 5 lM SKF (n = 7) as compared to that with the control analog
(n = 6). (C) and (D) The maintenance of potentiation induced by 10 lM SKF was unaffected by the treatment with either the CaMK inhibitor (n = 7) or the control drug KN-92
(n = 6). (E) and (F) Treatment with 10 lM KN-93 reduced the magnitude of the potentiation induced by 25 lM SKF (n = 8), compared to the treatment with 10 lM KN-92
(n = 6). (G) A histogram comparing the mean potentiation values at the end of the recording period in the respective SKF concentration groups with KN-93 or KN-92
treatment. No significant difference was observed between the treatments in 5 lM SKF and 10 lM SKF groups (Mann-Whitney U test; P > 0.05). However, treatment with
10 lM KN-93 significantly reduced the magnitude of potentiation in 25 lM SKF group (Mann-Whitney U test; ⁄P = 0.030). Error bars in all graphs represent ±SEM.
Representative fEPSP traces shown in each case were recorded at the respective time points as mentioned. Symbols and traces as in Fig. 1.
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Table 1
A summary of the effects of CaM-kinase inhibitor and MEK inhibitor during the induction (A) and maintenance (B) phase of the potentiation induced by
different concentrations of the D1/D5 receptor agonist SKF-38393.
SKF concentration (lM) Drug applied during induction phase Effect
A
5 lM SKF 1 lM KN-93 No potentiation
5 lM U0126 No potentiation
10 lM SKF 1 lM KN-93 Transient potentiation
5 lM U0126 Transient potentiation
25 lM SKF 1 lM KN-93 Long-lasting potentiation
5 lM U0126 Transient potentiation
SKF concentration (lM) Drug applied during maintenance phase Effect
B
5 lM SKF 1 lM KN-93 Long-lasting potentiation
10 lM KN-93 Long-lasting potentiation
10 lM SKF 1 lM KN-93 Long-lasting potentiation
10 lM KN-93 Long-lasting potentiation
25 lM SKF 1 lM KN-93 Long-lasting potentiation
10 lM KN-93 Long-lasting potentiation but reduced magnitude
M.S. Shetty, S. Sajikumar /Neurobiology of Learning and Memory xxx (2016) xxx–xxx 9In our study, we found no significant role for CaMKII activation
or for CaMKIV activation in the maintenance phase of the D1/D5
receptor-mediated potentiation. Application of CaMKII inhibitors
following LTP induction has been reported to have no effect on
LTP (Chen et al., 2001; Ito, Hidaka, & Sugiyama, 1991; Malinow
et al., 1989). Whether the CaMKII enzyme activity is transient or
persistent has been met with confounding results (Fukunaga
et al., 1995; Lee, Escobedo-Lozoya, Szatmari, & Yasuda, 2009;
Lengyel et al., 2004). The inhibitor KN-93 acts by allosterically
binding to CaMKII holoenzyme (in complex with Ca2+/CaM) and
blocking CaMKII activation. Hence, it only prevented the Ca2+/
calmodulin-dependent activation but not the autophosphorylated
form of the enzyme (Sumi et al., 1991; Vest, O’Leary, Coultrap,
Kindy, & Bayer, 2010); but no direct inhibitors of the autophospho-
rylated form are available currently. Therefore, from these results
we can only conclude that no persistent reactivation of the enzyme
was involved during the maintenance phase. However, on another
note, the autophosphorylated CaMKII is suggested to act as a
molecular switch (Lisman, 1994) at the transition of early and late
phases of LTP and in itself, this mechanism may not be able to sus-
tain the potentiation for long durations [Reviewed by (Giese &
Mizuno, 2013)]. A mutant deficient in threonine-286 autophospho-
rylation (T286A) (Giese et al., 1998) can still form memory upon
massed training, indicating that CaMKII is not absolutely essential
for certain forms memory storage (Irvine, von Hertzen, Plattner, &
Giese, 2006). Additionally, no impairment in the storage of contex-
tual fear long-term memory was seen following a post-training
blockade of CaMKII activity (Buard et al., 2010). Thus, CaMKII
involvement may be important only in certain forms of plasticity
and even in those forms, its activity may be restricted to certain
phases.
We also observed that only at stronger dopaminergic activation,
inhibition of both CaMKII and CaMKIV during the maintenance
phase resulted in a reduction in the magnitude of potentiation
though not completely blocking it. This suggests that CaMKIV-
mediated mechanisms might be involved only with sufficiently
stronger stimulation. Here, CaMKIV pathway might act synergisti-
cally with MEK/MAPK pathways to induce CREB activation (Wu,
Deisseroth, & Tsien, 2001). Besides, studies using mutant mice lines
have suggested that CaMKIV may be necessary for only certain
forms of memory, for instance, fear memory but not for spatial
memory (Ho et al., 2000; Kang et al., 2001; Wei et al., 2002). The
CaMKK-CaMKIV cascade is more sensitive to nuclear calcium entry
(Hardingham, Arnold, & Bading, 2001) which might efficiently hap-
pen at stronger stimulations.
These results indicate that at substantially weak levels of
dopaminergic stimulation, both CaMKII and MEK activation werePlease cite this article in press as: Shetty, M. S., & Sajikumar, S. Differential invo
vated protein kinases in the dopamine D1/D5 receptor-mediated potentiation i
ory (2016), http://dx.doi.org/10.1016/j.nlm.2016.07.020necessary for the induction of the slow-onset potentiation. At mod-
erate levels of stimulation, however, either one of these kinases
alone could maintain the potentiation transiently but a concerted
action of both appeared to be necessary for the maintenance of late
phase. Interestingly, when the dopaminergic activation was suffi-
ciently stronger, CaMKII mediated mechanisms became dispens-
able while MEK activation remained necessary, which supports
our earlier finding that MEK activation is crucial for D1/D5
receptor-mediated synaptic plasticity in hippocampal CA1 region
(Shivarama Shetty et al., 2016). These results are important in
understanding the dopaminergic modulation of hippocampal
synaptic plasticity which is involved in long-term memory storage
and also implicated in certain cognitive disorders.
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